Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation;A kétoldali subthalamicus stimuláció hatékonysága az antiparkinson gyógyszerelés változtatásának tükrében

Ideggyogyaszati Szemle

Volumn 63, Issue 9-10, 2010, Pages 314-319

  Fehér, Georgina ^a   Balás, István ^b   Komoly, Sámuel ^a   Dóczi, Tamás ^b   Janszky, József ^a   Aschermann, Zsuzsanna ^a   Balázs, Éva ^a   Nagy, Ferenc ^a   Kovács, Norbert ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Deep brain stimulation; Levodopa; Parkinson's disease; Subthalamic nucleus

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DRUG USE; HUMAN; IDIOPATHIC DISEASE; IMPLANTATION; MCNEMAR TEST; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE; WILCOXON SIGNED RANKS TEST; AGED; DRUG ADMINISTRATION; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 78349236301     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355(9):896-908. (Pubitemid 44315982)
2. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Jr., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301(1):63-73.
3. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21 Suppl 14:S290-304.
4. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18(5):467-86. (Pubitemid 36656531)
5. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006;21 Suppl 14:S171-96.
6. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002;17 Suppl 3:S94-101.
7. Balas I, Llumiguano C, Horvath Z, Kover F, Doczi T. Stereotactic thalamotomy for Parkinsonian and others types of tremor. Experiences of thalamic multiunit burst activity by means of semimicroelectrode. Rev Neurol 2001;32(6):520-4.
8. Kovács N, Balás I, Janszky J, Aschermann Z, Nagy F, Dóczi T, et al. Mélyagyi stimulátor beültetést követocombining double acute accent beteggondozás speciális kérdései. (Special aspects of patient care after implantation of deep-brain-stimulator.) Ideggyogy Sz 2008;61(1-2):4-15.
9. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40(3):355-66. (Pubitemid 26304793)
10. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009;8(1):67-81.
11. Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg 2005;103(6):956-67. (Pubitemid 43194543)
12. Zibetti M, Pesare M, Cinquepalmi A, Rosso M, Bergamasco B, Ducati A, et al. Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis. Parkinsonism Relat Disord 2008;14 (8):608-12.
13. Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000;57(7):983-8. (Pubitemid 30452503)
14. Vingerhoets FJ, Villemure JG, Temperli P, Polio C, Prolong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002; 58(3):396-401.
15. Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, et al. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol 2006;63(7):951-5.
16. Meissner W, Schreiter D, Volkmann J, Trottenberg T, Schneider GH, Sturm V, et al. Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany. J Neurol 2005;252(2):218-23. (Pubitemid 40385598)
17. McIntosh E, Gray A, Aziz T. Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Mov Disord 2003;18(9):993-9. (Pubitemid 37185206)
18. Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, et al. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol 2002;249(6):759-66. (Pubitemid 34651759)
19. Puig-Junoy J, Puig Peiro R. Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease. Neurologia 2009;24(4):220-9.
20. Valldeoriola F, Morsi O, Tolosa E, Rumia J, Marti MJ, Martinez-Martin P. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007;22(15):2183-91.
21. Fraix V, Houeto JL, Lagrange C, Le Pen C, Krystkowiak P, Guehl D, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77(4):443-9.